chr10-73136789-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_007265.3(ECD):c.1619A>T(p.Asp540Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000991 in 1,614,100 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_007265.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ECD | NM_007265.3 | c.1619A>T | p.Asp540Val | missense_variant | 13/14 | ENST00000372979.9 | NP_009196.1 | |
ECD | NM_001135752.1 | c.1718A>T | p.Asp573Val | missense_variant | 14/15 | NP_001129224.1 | ||
ECD | NM_001135753.1 | c.1490A>T | p.Asp497Val | missense_variant | 12/13 | NP_001129225.1 | ||
ECD | NR_024203.1 | n.1451A>T | non_coding_transcript_exon_variant | 11/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ECD | ENST00000372979.9 | c.1619A>T | p.Asp540Val | missense_variant | 13/14 | 1 | NM_007265.3 | ENSP00000362070.4 |
Frequencies
GnomAD3 genomes AF: 0.000776 AC: 118AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000831 AC: 209AN: 251488Hom.: 3 AF XY: 0.000979 AC XY: 133AN XY: 135920
GnomAD4 exome AF: 0.00101 AC: 1482AN: 1461848Hom.: 5 Cov.: 31 AF XY: 0.00104 AC XY: 756AN XY: 727218
GnomAD4 genome AF: 0.000775 AC: 118AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.000725 AC XY: 54AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2024 | The c.1718A>T (p.D573V) alteration is located in exon 14 (coding exon 13) of the ECD gene. This alteration results from a A to T substitution at nucleotide position 1718, causing the aspartic acid (D) at amino acid position 573 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at